End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.58 CNY | +0.67% | +1.40% | -15.13% |
Business Summary
Number of employees: 15,074
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiovascular and Cerebrovascular
45.6
%
| 4,178 | 33.3 % | 4,709 | 45.6 % | +12.71% |
Respiratory System
32.0
%
| 6,872 | 54.8 % | 3,305 | 32.0 % | -51.90% |
Other
18.1
%
| 1,101 | 8.8 % | 1,869 | 18.1 % | +69.72% |
Other Patented Products
4.2
%
| 383 | 3.1 % | 435 | 4.2 % | +13.82% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
97.7
%
| 12,070 | 96.3 % | 10,079 | 97.7 % | -16.50% |
Foreign
2.3
%
| 463 | 3.7 % | 239 | 2.3 % | -48.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xiang Jun Wu
CEO | Chief Executive Officer | 49 | 31/12/04 |
Chen Guang Li
DFI | Director of Finance/CFO | 51 | 31/12/96 |
Qiu Lian Zhang
BRD | Director/Board Member | 54 | 15/03/15 |
Rui Wu
BRD | Director/Board Member | 44 | 30/08/10 |
Hua Wang
IRC | Investor Relations Contact | - | - |
Shao Hua Zhao
PRN | Corporate Officer/Principal | 58 | 30/06/94 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Ling Wu
FOU | Founder | 75 | 27/08/01 |
Xiang Jun Wu
CEO | Chief Executive Officer | 49 | 31/12/04 |
Xue Dong Gao
CHM | Chairman | 54 | 30/08/10 |
Rui Wu
BRD | Director/Board Member | 44 | 30/08/10 |
Wei Dong Xu
BRD | Director/Board Member | 56 | 15/01/20 |
Gen Wu Liu
BRD | Director/Board Member | 51 | 17/08/14 |
Zhen Wang
BRD | Director/Board Member | 51 | 11/12/16 |
Qiu Lian Zhang
BRD | Director/Board Member | 54 | 15/03/15 |
Xiao Han Liu
BRD | Director/Board Member | 69 | 15/01/20 |
Pei Yong Gao
BRD | Director/Board Member | 59 | 03/06/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,670,705,376 | 696,455,299 ( 41.69 %) | 0 | 41.69 % |
Company contact information
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
No. 238 Tianshan Avenue High-tech Industrial Dev Zone
050035, Shijiazhuang
+86 311 8590 1712
http://www.yiling.cnSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.13% | 4.51B | |
+35.04% | 5.92B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B | |
+33.40% | 1.38B |
- Stock Market
- Equities
- 002603 Stock
- Company Shijiazhuang Yiling Pharmaceutical Co., Ltd.